Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

NCT00496275 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Zactima (ZD6474)
DRUG: Vinorelbine plus cisplatin
DRUG: Gemcitabine plus cisplatin

Sponsor

Genzyme, a Sanofi Company